Diplomat Pharmacy (Diplomat Pharmacy) Accounts Payable & Accrued Expense : $425 Mil (As of Sep. 2019)

View and export this data going back to 2014. Start your Free Trial

What is Diplomat Pharmacy Accounts Payable & Accrued Expense?

Diplomat Pharmacy's quarterly accounts payable & accrued expense increased from Mar. 2019 ($333 Mil) to Jun. 2019 ($393 Mil) and increased from Jun. 2019 ($393 Mil) to Sep. 2019 ($425 Mil).

Diplomat Pharmacy's annual accounts payable & accrued expense increased from Dec. 2016 ($333 Mil) to Dec. 2017 ($442 Mil) but then declined from Dec. 2017 ($442 Mil) to Dec. 2018 ($357 Mil).

Diplomat Pharmacy Accounts Payable & Accrued Expense Historical Data

The historical data trend for Diplomat Pharmacy's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diplomat Pharmacy Accounts Payable & Accrued Expense Chart

Diplomat Pharmacy Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

213.17

360.34

332.92

442.12

357.44

Diplomat Pharmacy Quarterly Data
	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															371.96	357.44	333.05	393.36	425.17

Diplomat Pharmacy Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Diplomat Pharmacy (Diplomat Pharmacy) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Diplomat Pharmacy Inc (NYSE:DPLO) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

4100 South Saginaw Street, Flint, MI, USA, 48507

Website

http://www.diplomat.is

Diplomat Pharmacy Inc. is active in the U.S. healthcare sector. It provides specialty pharmacy and infusion services, including pharmacy solutions for chronic diseases. The company has two main segments: specialty pharmacy and pharmacy benefit management. Its specialty pharmacy segment offers solutions to dispense, deliver, and dose prescription drugs. The pharmacy benefit management segment offers services to help control pharmacy benefit dollars and maximize quality of care. It derives most of its revenue through prescription drug sales in the United States.

Executives

Brian T Griffin	director, officer: Chairman and CEO
David C Dreyer	director	C/O SICOR INC, 19 HUGHES, IRVINE CA 92618-1902
Shawn Tomasello	director	C/O PHARMACYCLICS, INC, 995 EAST ARQUES AVENUE, SUNNYVALE CA 94085
Regina M. Benjamin	director	51 SAWYER ROAD, SUITE 200, WALTHAM MA 02453
Benjamin Wolin	director	C/O EVERYDAY HEALTH, INC., 345 HUDSON STREET, 16TH FLOOR, NEW YORK NY 10014
Jeffrey G Park	director	C/O DIPLOMAT PHARMACY, INC., 4100 S. SAGINAW ST., FLINT MI 48507
Sean Whelan	director, officer: Chief Financial Officer	C/O ZOMEDICA CORP., 100 PHOENIX DRIVE, SUITE 125, ANN ARBOR MI 48108
Jeffrey M Rowe	director, officer: EVP of Operations	C/O ZOMEDICA CORP., 100 PHOENIX DRIVE, SUITE 125, ANN ARBOR MI 48018